Akeso
Foreign stocks · Cancer drugs
Investors in Thailand can buy 9926.HK through 2 mutual funds open to retail investors. Most of them (2 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds 9926.HK.
| Fund | 9926.HK weight | How it invests | 1-year return |
|---|---|---|---|
| 5.51% | Via several master funds (Global X China Biotech, Kraneshares MSCI All China Health Care Index) | −2.99% | |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
| Master fund | Thai funds using this route | Master fund's 9926.HK weight |
|---|---|---|
| several master funds (Global X China Biotech, Kraneshares MSCI All China Health Care Index) | 1 | 5.51% |
| several master funds | 1 | 2.35% |
| 2.35% |
| Via several master funds |
| +0.22% |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 84.30 | 86.43 | Above |
| 20 days | 86.22 | 87.97 | Above |
| 50 days | 93.40 | 91.88 | Below |
| 100 days | 94.06 | 96.06 | Below |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 49.20 | Down |
| MACD(12,26) | −2.48 | Down |
| ADX(14) | 23.76 | Neutral |
| ATR(14) % of price | 3.33 | Neutral |
No financial statements for 9926.HK in the system yet — the share price above is the actual daily close
| Fund | 9926.HK weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| 5.51% | several master funds (Global X China Biotech, Kraneshares MSCI All China Health Care Index) | −2.99% | 1.86% | |
| 2.35% | several master funds | +0.22% | 1.73% |
| 200 days | 105.10 | 101.44 | Below |